Lexaria Bioscience Corp. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q3 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Lexaria Bioscience Corp. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q3 2013 to Q4 2024.
  • Lexaria Bioscience Corp. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending November 30, 2024 was $9.39M, a 179% increase year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $9.39M +$6.02M +179% Nov 30, 2024 10-Q 2025-01-10
Q3 2024 $7.66M +$4.98M +186% Aug 31, 2024 10-Q 2025-01-10
Q2 2024 $9.75M +$5.71M +141% May 31, 2024 10-Q 2024-07-12
Q1 2024 $6.15M +$1.52M +32.7% Feb 29, 2024 10-Q 2024-07-12
Q4 2023 $3.37M -$2.56M -43.1% Nov 30, 2023 10-Q 2025-01-10
Q3 2023 $2.68M -$4.95M -64.9% Aug 31, 2023 10-Q 2025-01-10
Q2 2023 $4.04M -$4.87M -54.7% May 31, 2023 10-Q 2024-07-12
Q1 2023 $4.63M -$6.59M -58.7% Feb 28, 2023 10-Q 2024-07-12
Q4 2022 $5.93M -$5.54M -48.3% Nov 30, 2022 10-Q 2024-07-12
Q3 2022 $7.63M -$3.84M -33.4% Aug 31, 2022 10-K 2024-11-26
Q2 2022 $8.91M -$1.35M -13.2% May 31, 2022 10-Q 2023-07-14
Q1 2022 $11.2M -$483K -4.13% Feb 28, 2022 10-Q 2023-07-14
Q4 2021 $11.5M +$9.65M +530% Nov 30, 2021 10-Q 2023-07-14
Q3 2021 $11.5M +$8.99M +362% Sep 30, 2021 10-Q 2022-07-14
Q2 2021 $10.3M +$7.07M +221% May 31, 2021 10-Q 2022-07-14
Q1 2021 $11.7M +$9.78M +509% Feb 28, 2021 10-Q 2022-07-14
Q4 2020 $1.82M -$794K -30.4% Nov 30, 2020 10-Q 2022-07-14
Q3 2020 $2.48M -$8.45K -0.34% Aug 31, 2020 10-K 2022-11-28
Q2 2020 $3.2M -$124K -3.74% May 31, 2020 10-Q 2021-04-14
Q1 2020 $1.92M -$1.85M -49% Feb 29, 2020 10-Q 2021-04-14
Q4 2019 $2.62M -$799K -23.4% Nov 30, 2019 10-Q 2021-04-14
Q3 2019 $2.49M +$103K +4.29% Aug 31, 2019 10-Q 2021-04-14
Q2 2019 $3.32M +$687K +26.1% May 31, 2019 10-Q 2020-06-30
Q1 2019 $3.77M +$1M +36.1% Feb 28, 2019 10-Q 2020-06-30
Q4 2018 $3.41M +$1.01M +42.2% Nov 30, 2018 10-Q 2020-06-30
Q3 2018 $2.39M -$380K -13.7% Aug 31, 2018 10-K 2020-10-15
Q2 2018 $2.64M -$422K -13.8% May 31, 2018 10-Q 2018-07-13
Q1 2018 $2.77M +$2.28M +465% Feb 28, 2018 10-Q 2018-04-12
Q4 2017 $2.4M +$1.78M +285% Nov 30, 2017 10-Q 2018-01-12
Q3 2017 $2.77M +$2.68M +3054% Aug 31, 2017 10-K 2019-11-14
Q2 2017 $3.06M +$3.1M May 31, 2017 10-Q 2017-07-14
Q1 2017 $491K +$385K +367% Feb 28, 2017 10-Q 2017-04-14
Q4 2016 $623K +$305K +95.6% Nov 30, 2016 10-Q 2017-01-13
Q3 2016 $87.8K -$569K -86.6% Aug 31, 2016 10-K 2018-11-14
Q2 2016 -$45.3K -$1.18M -104% May 31, 2016 10-Q 2016-07-13
Q1 2016 $105K -$1.07M -91% Feb 29, 2016 10-Q 2016-04-13
Q4 2015 $319K -$1.14M -78.2% Nov 30, 2015 10-Q 2016-01-08
Q3 2015 $657K -$1.06M -61.8% Aug 31, 2015 10-K 2018-11-14
Q2 2015 $1.14M May 31, 2015 10-Q 2015-07-14
Q1 2015 $1.17M Feb 28, 2015 10-Q 2015-04-14
Q4 2014 $1.46M Nov 30, 2014 10-Q 2015-01-14
Q3 2014 $1.72M -$382K -18.2% Aug 31, 2014 10-K 2016-11-29
Q3 2013 $2.1M Oct 31, 2013 10-K 2015-11-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.